Stock Scorecard
Stock Summary for Humacyte Inc (HUMA) - $1.89 as of 5/16/2025 3:19:47 PM EST
Total Score
5 out of 30
Safety Score
26 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HUMA
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HUMA
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HUMA
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HUMA
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for HUMA (26 out of 100)
Stock Price Rating (Max of 10) | 2 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HUMA
Financial Details for HUMA
Company Overview |
|
---|---|
Ticker | HUMA |
Company Name | Humacyte Inc |
Country | USA |
Description | N/A |
Sector Name | REAL ESTATE & CONSTRUCTION |
Industry Name | BLANK CHECKS |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 1.89 |
Price 4 Years Ago | 7.25 |
Last Day Price Updated | 5/16/2025 3:19:47 PM EST |
Last Day Volume | 6,853,101 |
Average Daily Volume | 3,988,235 |
52-Week High | 9.97 |
52-Week Low | 1.15 |
Last Price to 52 Week Low | 64.35% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 123.25 |
Sector PE | 62.11 |
5-Year Average PE | -9.93 |
Free Cash Flow Ratio | 6.52 |
Industry Free Cash Flow Ratio | 115.83 |
Sector Free Cash Flow Ratio | 94.47 |
Current Ratio Most Recent Quarter | 2.40 |
Total Cash Per Share | 0.29 |
Book Value Per Share Most Recent Quarter | 0.23 |
Price to Book Ratio | 30.28 |
Industry Price to Book Ratio | 3.35 |
Sector Price to Book Ratio | 12.34 |
Price to Sales Ratio Twelve Trailing Months | 567.07 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.71 |
Sector Price to Sales Ratio Twelve Trailing Months | 4.86 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 155,119,000 |
Market Capitalization | 293,174,910 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -34.24% |
Reported EPS 12 Trailing Months | -1.26 |
Reported EPS Past Year | -0.08 |
Reported EPS Prior Year | -1.31 |
Net Income Twelve Trailing Months | -148,701,000 |
Net Income Past Year | -148,701,000 |
Net Income Prior Year | -110,776,000 |
Quarterly Revenue Growth YOY | -100.00% |
5-Year Revenue Growth | -100.00% |
Operating Margin Twelve Trailing Months | -4,484.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 44,937,000 |
Total Cash Past Year | 44,937,000 |
Total Cash Prior Year | 80,448,000 |
Net Cash Position Most Recent Quarter | -17,180,000 |
Net Cash Position Past Year | 6,337,000 |
Long Term Debt Past Year | 38,600,000 |
Long Term Debt Prior Year | 38,600,000 |
Total Debt Most Recent Quarter | 62,117,000 |
Equity to Debt Ratio Past Year | 0.00 |
Equity to Debt Ratio Most Recent Quarter | -5.57 |
Total Stockholder Equity Past Year | -52,669,000 |
Total Stockholder Equity Prior Year | 13,546,000 |
Total Stockholder Equity Most Recent Quarter | -52,669,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -99,694,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.64 |
Free Cash Flow Past Year | -99,694,000 |
Free Cash Flow Prior Year | -75,585,000 |
Options |
|
Put/Call Ratio | 0.10 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.09 |
MACD Signal | -0.19 |
20-Day Bollinger Lower Band | 0.39 |
20-Day Bollinger Middle Band | 3.01 |
20-Day Bollinger Upper Band | 5.63 |
Beta | 1.64 |
RSI | 61.62 |
50-Day SMA | 4.80 |
150-Day SMA | 3.83 |
200-Day SMA | 0.00 |
System |
|
Modified | 5/17/2025 2:08:09 AM EST |